AI assistant
Sending…
MEDIFAST INC — Director's Dealing 2023
Jun 20, 2023
33899_dirs_2023-06-20_288f0666-9490-49f3-8245-7b95d0b1168f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-06-15
Reporting Person: Hoer Michael A. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-15 | Common Stock | A | 3118 | — | Acquired | 8288.065 | Direct |
Footnotes
F1: Represents the right to receive 3,118 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024.
More from MEDIFAST INC
Regulatory Filings
2026
May 26
Annual Report
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 20
Regulatory Filings
2026
Mar 20
Annual Report
2026
Feb 17